BRIEF-Valeant gets lender approval to file annual report by May 31

Thu Apr 7, 2016 7:56am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

April 7 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant Pharmaceuticals receives lender consent for credit facility amendment

* Intends to file 10-K on or before April 29, 2016 , as previously disclosed

* Intends to file 10-K on or before April 29, 2016 , as previously disclosed

* Company expects to close amendment and waiver next week

* Expects to close amendment and waiver next week

* Says pursuant to approved waiver, deadline for filing company's form 10-K will be extended to May 31, 2016

* Waiver and amendment were approved by lenders holding more than 50 pct of company's loans in principal amount

* Says deadline for filing its form 10-Q for quarter ended March 31, 2016 will be extended to July 31 , 2016   Continued...